BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24670573)

  • 1. Clinical significance of residual lesions in chest computed tomography after anti-tuberculosis treatment.
    Seon HJ; Kim YI; Lim SC; Kim YH; Kwon YS
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):341-6. PubMed ID: 24670573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological manifestations of pulmonary tuberculosis in patients subjected to anti-TNF-α treatment.
    Huang LK; Wu MH; Chang SC
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):95-101. PubMed ID: 24365560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of low-dose computed tomography to assess pulmonary tuberculosis among healthcare workers in a tuberculosis hospital.
    He W; Chen BD; Lv Y; Zhou Z; Xu JP; Lv PX; Zhou XH; Ning FG; Li CH; Wang DP; Zheng J
    Infect Dis Poverty; 2017 Mar; 6(1):68. PubMed ID: 28335802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis.
    Kim W; Lee KS; Kim HS; Koh WJ; Jeong BH; Chung MJ; Jang HW
    Acta Radiol; 2016 Feb; 57(2):197-204. PubMed ID: 25759483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution chest CT in patients with pulmonary tuberculosis: characteristic findings before and after antituberculous therapy.
    Lee JJ; Chong PY; Lin CB; Hsu AH; Lee CC
    Eur J Radiol; 2008 Jul; 67(1):100-4. PubMed ID: 17870275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy.
    Im JG; Itoh H; Shim YS; Lee JH; Ahn J; Han MC; Noma S
    Radiology; 1993 Mar; 186(3):653-60. PubMed ID: 8430169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
    Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients.
    Lee ES; Park CM; Goo JM; Yim JJ; Kim HR; Lee HJ; Lee IS; Im JG
    J Comput Assist Tomogr; 2010 Jul; 34(4):559-63. PubMed ID: 20657225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable characteristics of tuberculous and non-tuberculous mycobacterial cavitary lung diseases.
    Kim YK; Hahn S; Uh Y; Im DJ; Lim YL; Choi HK; Kim HY
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):725-9. PubMed ID: 24903945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K; Kawabata S; Masuda N
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen.
    Jo KW; Yoo JW; Hong Y; Lee JS; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Apr; 108(4):654-9. PubMed ID: 24518046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F; Mahan CS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary tuberculosis after hematopoietic stem cell transplantation: radiologic findings.
    Jung JI; Lee DG; Kim YJ; Yoon HK; Kim CC; Park SH
    J Thorac Imaging; 2009 Feb; 24(1):10-6. PubMed ID: 19242297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inactive pulmonary tuberculosis and treatment sequelae: chest radiographic features.
    Hicks A; Muthukumarasamy S; Maxwell D; Howlett D
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):128-33. PubMed ID: 24429302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
    Saunders MJ; Koh GC; Small AD; Dedicoat M
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT of parenchymal and bronchial tuberculosis.
    Beigelman C; Sellami D; Brauner M
    Eur Radiol; 2000; 10(5):699-709. PubMed ID: 10823618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tomographic Aspects of Advanced Active Pulmonary Tuberculosis and Evaluation of Sequelae following Treatment.
    Capone RB; Capone D; Mafort T; Mogami R; Rodrigues RS; Menna Barreto M; Rufino R
    Pulm Med; 2017; 2017():9876768. PubMed ID: 28261498
    [No Abstract]   [Full Text] [Related]  

  • 20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.